Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Theillet

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Cancer Letters|April 4, 2024
CDK inhibition results in pharmacologic BRCAness increasing sensitivity to olaparib in BRCA1-WT and olaparib resistant in Triple Negative Breast CancerEsin Orhan, Carolina Velazquez, Imene Tabet, et al.
International Journal of Cancer|November 26, 2002
MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancerJohannes W G Janssen, Marguerite Cuny, Béatrice Orsetti, et al.
Cancer Medicine|March 10, 2025
Prognostic Value of Trop-2 Expression in Nonmetastatic Triple-Negative Breast Cancer and Correlation With Emerging BiomarkersWilliam Jacot, Marie-Christine Chateau, Simon Thezenas, et al.
The Journal of Pathology|March 18, 2022
In high-grade ovarian carcinoma, platinum-sensitive tumor recurrence and acquired-resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and SOX2Stanislas du Manoir, Hélène Delpech, Béatrice Orsetti, et al.
BMC Cancer|April 26, 2003
Genetic variability in MCF-7 sublines: evidence of rapid genomic and RNA expression profile modificationsMélanie Nugoli, Paul Chuchana, Julie Vendrell, et al.
Cancer Research|January 29, 2025
Replication-Poison Treatment in BRCA1-Deficient Breast Cancer Causes MRE11 Over-Resection That Induces Single-Stranded DNA Accumulation and Mitotic CatastropheImene Tabet, Esin Orhan, Ermes Candiello, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2006
Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 geneSelma El Messaoudi, Eric Fabbrizio, Carmen Rodriguez, et al.
Cancer Research|September 18, 2004
Genomic and expression profiling of chromosome 17 in breast cancer reveals complex patterns of alterations and novel candidate genesBéatrice Orsetti, Mélanie Nugoli, Nathalie Cervera, et al.
International Journal of Molecular Sciences|May 28, 2022
Multiplexed-Based Assessment of DNA Damage Response to Chemotherapies Using Cell Imaging CytometryNadia Vezzio-Vié, Marie-Alice Kong-Hap, Eve Combès, et al.
The American Journal of Pathology|March 26, 2011
Prognostic significance of TRIM24/TIF-1α gene expression in breast cancerMonique Chambon, Béatrice Orsetti, Marie-Laurence Berthe, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Cancer Letters|April 4, 2024
CDK inhibition results in pharmacologic BRCAness increasing sensitivity to olaparib in BRCA1-WT and olaparib resistant in Triple Negative Breast CancerEsin Orhan, Carolina Velazquez, Imene Tabet, et al.
International Journal of Cancer|November 26, 2002
MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancerJohannes W G Janssen, Marguerite Cuny, Béatrice Orsetti, et al.
Cancer Medicine|March 10, 2025
Prognostic Value of Trop-2 Expression in Nonmetastatic Triple-Negative Breast Cancer and Correlation With Emerging BiomarkersWilliam Jacot, Marie-Christine Chateau, Simon Thezenas, et al.
The Journal of Pathology|March 18, 2022
In high-grade ovarian carcinoma, platinum-sensitive tumor recurrence and acquired-resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and SOX2Stanislas du Manoir, Hélène Delpech, Béatrice Orsetti, et al.
BMC Cancer|April 26, 2003
Genetic variability in MCF-7 sublines: evidence of rapid genomic and RNA expression profile modificationsMélanie Nugoli, Paul Chuchana, Julie Vendrell, et al.
Cancer Research|January 29, 2025
Replication-Poison Treatment in BRCA1-Deficient Breast Cancer Causes MRE11 Over-Resection That Induces Single-Stranded DNA Accumulation and Mitotic CatastropheImene Tabet, Esin Orhan, Ermes Candiello, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2006
Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 geneSelma El Messaoudi, Eric Fabbrizio, Carmen Rodriguez, et al.
Cancer Research|September 18, 2004
Genomic and expression profiling of chromosome 17 in breast cancer reveals complex patterns of alterations and novel candidate genesBéatrice Orsetti, Mélanie Nugoli, Nathalie Cervera, et al.
International Journal of Molecular Sciences|May 28, 2022
Multiplexed-Based Assessment of DNA Damage Response to Chemotherapies Using Cell Imaging CytometryNadia Vezzio-Vié, Marie-Alice Kong-Hap, Eve Combès, et al.
The American Journal of Pathology|March 26, 2011
Prognostic significance of TRIM24/TIF-1α gene expression in breast cancerMonique Chambon, Béatrice Orsetti, Marie-Laurence Berthe, et al.
Pageof 6